Differential retinoblastoma protein expression in neuroendocrine tumors of the lung: Potential diagnostic implications

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 393-400

  Cagle, Philip T ^a   El Naggar, Adel K ^b   Xu, Hong Ji ^b   Hu, Shi Xue ^b   Benedict, William F ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHUS CARCINOID; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COHORT STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; RETINOBLASTOMA PROTEIN; STAINING AND LABELING;

EID: 0031017339     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gould VE, Linnoila RI, Memoli VA, Warren WH: Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu 1983, 18:287-330
2. Carter D, Yesner R: Carcinomas of the lung with neuroendocrine differentiation. Semin Diagn Pathol 1985, 2:235-254
3. Hammar S, Bockus D, Remington F, Cooper L: The unusual spectrum of neuroendocrine lung neoplasms. Ultrastruct Pathol 1989, 13:515-560
4. Warren WH, Faber LP, Gould VE: Neuroendocrine neoplasms of the lung: a clinicopathologic update. J Thorac Cardiovasc Surg 1989, 98:321-332
5. Cagle PT: Tumors of the lung (excluding lymphoid tumors). Pathology of the Lung, ed 2. Edited by Thurlbeck WM, Churg AM. New York, Thieme Medical Publishers, Inc, 1995, pp 437-552
6. Francioni F, Rendina EA, Venuta F, Pescarmona E, DeGiacomo T, Ricci C: Low grade neuroendocrine tumors of the lung (bronchial carcinoids)-25 years experience, Eur J Cardiothorac Surg 1990, 4:472-476
7. Akiba T, Naruke T, Kondo H, Goya T, Tsuchiya R, Suemasu K, Noguchi M, Sakurai K: Carcinoid tumor of the lung: clinicopathological study of 32 cases. Jpn J Clin Oncol 1992, 22:92-95
8. Ishida T, Yokoyama H, Sugio K, Kaneko S, Sugimachi K, Hara N, Ohta M: Carcinoid tumor of the lung: clinicopathological and immunohistochemical studies, Eur J Surg Oncol 1992, 18:180-187
9. Travis WD, Linnoila Rl, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma, An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases, Am J Surg Pathol 1991, 15:529-553
10. Cagle PT: Molecular pathology of lung cancer and its clinical relevance. Current Concepts in Pulmonary Pathology, Edited by Katzenstein A-L, Churg A, Los Angeles, University of Southern California Press, 1993, pp 134-144
11. Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla Palma P, Doglioni C: Tumor suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 1992, 166:343-350
12. Gouyer V, Gazzeri S, Brambilla E, Boion I, Moro D, Perron P, Benabtd AL, Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas, Int J Cancer 1994, 58:818-824
13. Lai S-L, Brauch H, Knutsen T, Johnson BE, Nau MM, Mitsudomi T, Tsai C-M, Whang-Peng J, Zbar B, Kaye FJ, Gazdar AF: Molecular genetic characterization of neuroendocrine lung cancer cell lines, Anticancer Res 1995, 15:225-232
14. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky NF, Bakker A, Guinee DG, Koss M, Travis WD: Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological subtype and clinical outcome. Am J Pathol 1996, 148:1531-1541
15. Benedict WF, Xu H-J, Takahashi, R: The role of the retinoblastoma gene in initiation and progression of human cancer. J Clin Invest 1990, 85:988-993
16. 1 cells: correlation to changes in total RB protein level. Oncogene 1991, 6:1139-1144
17. Xu H-J: Altered retinoblastoma (RB) protein expression in human malignancies, Adv Anat Pathol 1995, 2:213-226
18. Zhang X, Xu H-J, Murahami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict WF, Sekiya T: Deletions of chromosome 13q mutations in RB1 and RB protein state in human hepatocellular carcinoma. Cancer Res 1994, 54:4177-4182
19. Xu H-J, Quinlan DC, Davidson AG, Hu S-X, Summers CL, Li J, Benedict WF: Altered retinoblastoma protein expression and prognosis in early-state non-small cell lung carcinoma. J Natl Cancer Inst 1994, 86:695-699
20. Geradts J, Hu S-X, Lincoln CE, Benedict WF, Xu H-J: Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies, Int J Cancer 1994, 58:161-167
21. Xu H-J, Cagle PT, Hu S-X, Li J, Benedict WF: Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis. Clin Cancer Res 1996, 2:1169-1176
22. Cattoretti G, Becker MHG, Key G, Duchrow M, Schulter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 Antigen (MIB and MIB 3) detect proliferating cells in microwave-processed, formalin-fixed paraffin sections. J Pathol 1992, 168: 357-363
23. Cattoretti G, Pileri S, Parraviccini C, Becker MHG, Poggi S, Biufulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F: Antigen unmasking of formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993, 171:83-98
24. Xu H-J, Hu S-X, Hashimoto T, Takahashi R, Benedict WF: The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 1989, 4:807-812
25. Xu H-J, Hu S-X, Cagle PT, Moore GE, Benedict WF: Absence of RB protein expression in primary non-small cell lung carcinomas. Cancer Res 1991, 51:2735-2739
26. Logothetis CJ, Xu H-J, Ro JY, Hu S-X, Sahin A, Ordonez N, Benedict WF: Altered retinoblastoma protein expression and known prognostic variables in locally advanced bladder cancer, J Natl Cancer Inst 1992, 84:1256-1261
27. Xu H-J, Cairns P, Hu S-X, Knowles MA, Benedict WF: Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 1993, 53: 781-784
28. Kubota Y, Miyamoto H, Noguchi S, Shuin T, Kitamura H, Xu H-J, Hu S-X, Benedict WF: The loss of retinoblastoma gene in association with C-myc and TGF-B1 genes expression in human bladder cancer, J Urol 1995, 154:371-374
29. Cryns VL, Thor A, Xu H-J, Hu S-X, Vickery A, Benedict WF, Arnold A: Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 1994, 330:757-761
30. Kim TM, Benedict WF, Xu H-J, Gosewehr J, Hu S-X, Velicescu M, Yin E, Zheng J, D'Ablaing G, Dubeau L: Loss of heterozygosity on chromosome 13q is associated with the biologically more aggressive subtypes of ovarian epithelial tumors and do not result in loss of retinoblastoma gene expression. Cancer Res 1994, 54:605-609
31. Dodson MK, Cliby WA, Xu H-J, DeLacey KA, Hu S-X, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF: Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus, Cancer Res 1994, 54:610-613
32. Yoo GH, Xu H-J, Westra W, Hruban RH, Koch W, Benedict WF, Sidransky D: Rare inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994, 54:4603-4606
33. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D: Frequent loss of heterozygosity at the RB locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995, 8:1613-1616
34. Walther MM, Gnarra J, Elwood L, Xu H-J, Florence C, Anglard P, Hu S-X, King C, Trahan E, Hurley K, Sens D, Venzon D, Liu S, Jaffe GS, Benedict WF, Linehan WM: Loss of heterozygosity occurs centromeric to RB, without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma. J Urol 1995, 153:2050-2054
35. Henson JW, Schnitker BL, Correa KM, vonDeimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994, 36:714-721
36. Hurr K, Kemp B, Silver SA, EI-Naggar AK: Microsatellite alteration at chromosome 3p loci in neuroendocrine and nonneuroendocrine lung tumors: histogenetic and clinical relevance, Am J Patho 1996, 149: 613-620
37. Cance WG, Brennan MR, Dudas ME, Huang CM, Cordon-Cardo C: Altered expression of the retinoblastoma gene product in human sarcomas, N Engl J Med 1990, 323:1457-1462
38. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992, 84:1251-1256